ABOT Pharmaceuticals: Major
Health Technology
Mkt Cap
86.6B
P/E (TTM)
10.43
EPS
81.37
ROE
28.59%
Div Yield
4.52%

About

Abbott Laboratories (Pakistan) Ltd. engages in the manufacture, import, and marketing of pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. It operates through the following segments: Pharmaceutical, Nutritional, Diagnostics, and Others. The Pharmaceutical segment deals with the manufacture, import, and marketing of research based pharmaceutical products registered with the Drug Regulatory Authority of Pakistan. The Nutritional segment imports and markets pediatric nutritional products and medical nutritional products. The Diagnostics segment covers the import and marketing of diagnostic equipment, molecular devices, and testing kits. The Others segment represents the import and marketing of diabetes care products and manufacturing and marketing of general healthcare products. The company was founded on July 2, 1948 and is headquartered in Karachi, Pakistan.

Financial Highlights

FY2025FY2024FY2023FY2022FY2021
Revenue75.40B68.18B55.48B49.26B42.57B
Gross Profit26.45B18.89B11.34B13.88B15.35B
Net Income7.97B5.23B261.78M3.00B5.97B
EPS81.3753.462.6730.6960.95
ROE28.79%24.95%1.48%17.44%36.22%
ROA18.79%13.95%0.73%9.52%22.20%
Gross Margin35.08%27.71%20.44%28.17%36.06%
Net Margin10.57%7.68%0.47%6.10%14.02%
Current Ratio2.321.991.381.501.97
DPS40.0010.000.0015.0040.00
Free Cash Flow7.97B2.11B-2.41B1.11B6.27B